BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 15926166)

  • 1. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peak bone mineral density, lean body mass and fractures.
    Boot AM; de Ridder MA; van der Sluis IM; van Slobbe I; Krenning EP; Keizer-Schrama SM
    Bone; 2010 Feb; 46(2):336-41. PubMed ID: 19833245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density in long-term survivors of childhood cancer.
    Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
    Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
    Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
    Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
    Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
    Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
    Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
    Hartman A; te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Kemper HC; Hop WC; van den Heuvel-Eibrink MM; Pieters R
    Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone mineral density in children before and after completion of cancer treatment].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Kaczmarski M; Piotrowska-Jastrzebska J
    Pol Merkur Lekarski; 2004 Jul; 17(97):37-42. PubMed ID: 15559608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal morbidity in childhood acute lymphoblastic leukemia.
    Mandel K; Atkinson S; Barr RD; Pencharz P
    J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation.
    Bongers ME; Francken AB; Rouwé C; Kamps WA; Postma A
    Pediatr Blood Cancer; 2005 Aug; 45(2):139-43. PubMed ID: 15714445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia.
    van den Heijkant S; Hoorweg-Nijman G; Huisman J; Drent M; van der Pal H; Kaspers GJ; Delemarre-van de Waal H
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e231-8. PubMed ID: 21792029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
    Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
    Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mass and body composition after cessation of therapy for childhood cancer.
    Nysom K; Mølgaard C; Holm K; Hertz H; Michaelsen KF
    Int J Cancer Suppl; 1998; 11():40-3. PubMed ID: 9876476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body composition and bone mass in survivors of childhood cancer.
    Muszynska-Roslan K; Konstantynowicz J; Krawczuk-Rybak M; Protas P
    Pediatr Blood Cancer; 2007 Feb; 48(2):200-4. PubMed ID: 16602116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.